Jennison Associates LLC Scholar Rock Holding Corp Transaction History

Jennison Associates LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 05, 2024	BUY	$7.84 - $16.79 $18,173 - $38,919	2,318 Added 1.67%	140,776 $1.17 Million
Q1 2024 May 02, 2024	BUY	$13.2 - $17.76 $18,598 - $25,023	1,409 Added 1.03%	138,458 $2.46 Million
Q4 2023 Feb 01, 2024	BUY	$6.52 - $20.32 $893,559 - $2.78 Million	137,049 New	137,049 $2.58 Million

175

75.6M

585K

862K

Ticker SRRK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,640,600
Market Cap $2.17B
Description
Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clini...

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

Stay updated on Jennison Associates LLC with notifications on news.